Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02193425 · ClinicalTrials.gov registry record · Early Phase 1
Reliability of the Human Brain Connectome
A Early Phase 1 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Early Phase 1
- Development phase
- 112
- Enrollment target
NCT02193425 is a Early Phase 1 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 112 participants.
The verdict
NCT02193425, a Early Phase 1 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 112 participants
- Enrollment target
Study Summary
Background: \- Magnetic resonance imaging (MRI) is used to investigate brain function. Researchers want to use MRI to better understand the function patterns and connections between brain regions in healthy people. This might help people with brain diseases in the future. Objectives: * To evaluate MRI methods performed twice on the same day. * To evaluate brain function using positron emission tomography (PET). Eligibility: \- Healthy volunteers at least 18 years old. Design: * Visit 1: * Participants will be screened with medical history, physical exam, and interview about drug and alcohol use and psychiatric history. * They will give blood and urine samples. Their breath will be tested for alcohol and smoking. * Visit 2: * Participants will have urine collected. They will have MRI scans, some while resting, some while doing tasks on a computer. * The MRI scanner is a metal cylinder in a strong magnetic field. Participants will lie on a table that slides in and out of the cylinder, with a coil over their head. Participants will get earplugs for loud noises. * Visit 3: * Participants will have urine collected. * A needle will guide a thin plastic tube (catheter) into each arm. The needle will be removed, leaving the catheter in the vein. * Participants will then have a PET scan. They will get the chemical 18FDG in the catheter. They will lie on a bed that slides in and out of the PET scanner, with a cap on their head. * Participants may have tests of memory, attention, concentration, and thinking. They may complete interviews, questionnaires, tests on paper or computer, and simple actions. * Participants will wear a device for 1 week between visits to measure activity and sleep.
Interventions
- DEVICE MRI
- DRUG F-18FDG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2015-06-08 |
| Est. Completion | 2023-05-23 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02193425
The ClinicalTrials.gov registry entry for NCT02193425 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT02193425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02193425 about?
NCT02193425 is a clinical study titled "Reliability of the Human Brain Connectome". Background: \- Magnetic resonance imaging (MRI) is used to investigate brain function. Researchers want to use MRI to better understand the function patterns and connections between brain regions in healthy people. This might help people with brain diseases in the future. Objectives: * To evaluat...
What is the current status of trial NCT02193425?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 112 participants. The study started on 2015-06-08. Estimated completion is 2023-05-23.
What interventions are being tested in trial NCT02193425?
The interventions under investigation include: MRI (DEVICE), F-18FDG (DRUG).
Who is sponsoring clinical trial NCT02193425?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.